🇺🇸 FDA
Pipeline program

Mycophenolate Mofetil

ON/2016/6004

Phase 3 small_molecule completed

Quick answer

Mycophenolate Mofetil for Immune Thrombocytopenia is a Phase 3 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiff Oncology
Indication
Immune Thrombocytopenia
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials